Procollagen type I N-terminal propeptide

There are 52 papers on procollagen type I N-terminal propeptide in aging research: 17 trials and 17 observational studies in people, 11 in animals, 7 reviews. The newest story, Oct 25, 2026: “Engineered bone-targeting particles reduced bone loss in mice”.

Biomarker

52 papers study it59 more mention it15 findings

8 new papers in 30 daysSee all 111 papers on procollagen type I N-terminal propeptide

“The increase in PTH levels with age showed a positive linear correlation with P1NP and β-CTX concentrations and a negative linear correlation with BMD at the lumbar spines and the femoral neck.”
Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral densityOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2016doi:10.1007/s00198-015-3475-5
  • Human trial17
  • Humans17
  • Animals11

Interventions

7

Collagen peptides

no changein humans1upin humans1

1 study
  1. Collagen peptides showed no clear effect on procollagen type I N-terminal propeptide in humans.

    “Post-hoc pairwise comparisons revealed that 30 g HC had a greater PINP response than 0 g HC (P = 0.002) and 15 g HC (P = 0.020), whereas 15 g HC did not differ from 0 g HC (P = 0.245).”

    Human trial15 g7-h periodmalesn = 10

    The Collagen Synthesis Response to an Acute Bout of Resistance Exercise Is Greater when Ingesting 30 g Hydrolyzed Collagen Compared with 15 g and 0 g in Resistance-Trained Young Men

    The Journal of nutrition

  2. Collagen peptides increase procollagen type I N-terminal propeptide in humans.

    “Post-hoc pairwise comparisons revealed that 30 g HC had a greater PINP response than 0 g HC (P = 0.002) and 15 g HC (P = 0.020), whereas 15 g HC did not differ from 0 g HC (P = 0.245).”

    Human trial30 g7-h periodmalesn = 10

    The Collagen Synthesis Response to an Acute Bout of Resistance Exercise Is Greater when Ingesting 30 g Hydrolyzed Collagen Compared with 15 g and 0 g in Resistance-Trained Young Men

    The Journal of nutrition

  3. Collagen peptides showed no clear effect on procollagen type I N-terminal propeptide in humans (before high-intensity RE) (P = 0.225).

    “there was no difference between 0 and 15 g HC (P = 0.225)”

    Human trialbefore high-intensity REwith 50 mg vitamin C15 g vs 0 gmalesn = 10

    The Collagen Synthesis Response to an Acute Bout of Resistance Exercise Is Greater when Ingesting 30 g Hydrolyzed Collagen Compared with 15 g and 0 g in Resistance-Trained Young Men

    The Journal of nutrition

  4. Collagen peptides increase procollagen type I N-terminal propeptide in humans (before high-intensity RE) (267 ± 79 vs 235 ± 70 μg·L−1·h (P = 0.013) and 219 ± 88 μg·L−1·h (P = 0.002)).

    “serum PINP concentration × time area under the curve (AUC) was greater for 30 g (267 ± 79 μg·L−1·h) than for 15 g (235 ± 70 μg·L−1·h, P = 0.013) and 0 g HC”

    Human trialbefore high-intensity REwith 50 mg vitamin C30 gmalesn = 10

    The Collagen Synthesis Response to an Acute Bout of Resistance Exercise Is Greater when Ingesting 30 g Hydrolyzed Collagen Compared with 15 g and 0 g in Resistance-Trained Young Men

    The Journal of nutrition

More on Collagen peptides

Spicy food

upin humans1

1 study
  1. Spicy food is linked with higher procollagen type I N-terminal propeptide in humans.

    “daily consumption of spicy food was positively associated with serum PINP levels”

    Humans

    Association between daily consumption of spicy food and bone mineral density in middle-aged and older adults: a cross-sectional study

    Food & function

More on Spicy food

Brisk walking + jumping

downin humans1

1 study
  1. Brisk walking + jumping decreases procollagen type I N-terminal propeptide in humans (Premenopausal women; compared with usual lifestyle) (-6.74 μg/L versus control).

    “significant differences between groups in procollagen Type 1 N-terminal propeptide (-6.74 μg/L, p = .023) and C-terminal telopeptide of Type I collagen (-83 ng/L, p = .043)”

    Human trialPremenopausal women; compared with usual lifestyleAt least 10,000 brisk walking steps and 60 jumps exceeding 4g daily3 monthsfemales

    Assessment of Osteogenic Exercise Efficacy via Bone Turnover Markers in Premenopausal Women: A Randomized Controlled Trial

    International journal of sport nutrition and exercise metabolism

More on Brisk walking + jumping

Vitamin D

downin humans1

1 study
  1. Vitamin D decreases procollagen type I N-terminal propeptide in humans (subgroup analysis).

    “vitamin D administration notably reduced procollagen type I N-terminal propeptide (PINP) levels in individuals aged >50 years”

    Reviewsubgroup analysis

    Impact of vitamin D supplementation on markers of bone turnover: Systematic review and meta-analysis of randomised controlled trials

    European journal of clinical investigation

More on Vitamin D

Musa paradisiaca

upin rats1

1 study
  1. Musa paradisiaca increases procollagen type I N-terminal propeptide in rats (ovariectomized osteopenic bone loss model).

    “they elevated serum procollagen type I N-terminal propeptide (P1NP), a bone formation marker and suppressed serum C-telopeptide of type I collagen (CTX-1)”

    Animalsovariectomized osteopenic bone loss modelethanolic flower extract and butanolic fractionfemales

    Extract and fraction of Musa paradisiaca flower have osteogenic effect and prevent ovariectomy induced osteopenia

    Phytomedicine : international journal of phytotherapy and phytopharmacology

More on Musa paradisiaca

Testosterone undecanoate

downin humans1

1 study
  1. Testosterone undecanoate decreases procollagen type I N-terminal propeptide in humans (dieting obese men with low testosterone) (MAD -5.6 ug/L (95% CI -10.1, -1.1), p = 0.03).

    “P1NP was marginally increased after VLED, MAD +4.2 ug/L (95% CI -0.01, +8.4), p = 0.05 but lower at study end, MAD -5.6 ug/L (95% CI -10.1, -1.1), p = 0.03.”

    Human trialdieting obese men with low testosteroneintramuscular56 weeksmalesn = 100

    Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial

    Scientific reports

More on Testosterone undecanoate

Bovine collagen peptides + calcium citrate

upin rats1

1 study
  1. Bovine collagen peptides + calcium citrate increases procollagen type I N-terminal propeptide in OVX rats.

    “CP or CP-calcium citrate administration significantly increased serum procollagen type I N-terminal propeptide levels”

    Animalsin OVX ratsoralserum3 months

    Combined oral administration of bovine collagen peptides with calcium citrate inhibits bone loss in ovariectomized rats

    PloS one

More on Bovine collagen peptides + calcium citrate

Associations

5

Primary osteoporosis

upin humans1

1 study
  1. Procollagen type I N-terminal propeptide is associated with primary osteoporosis in humans (Community-dwelling middle-aged and older women).

    “elevated OST and PINP levels and imbalanced constitutions such as qi deficiency/yang deficiency/yin deficiency/damp-heat/blood stasis/qi stagnation indicated higher risk.”

    HumansCommunity-dwelling middle-aged and older womenfemalesn = 1,186

    Risk factors for osteoporosis and development of a risk prediction model in community-dwelling middle-aged and older women

    Chinese Journal of Gerontology

More on Primary osteoporosis

Abnormal bone mineral density

mixedin humans1

1 study
  1. Procollagen type I N-terminal propeptide is associated with abnormal bone mineral density in humans (perimenopausal women).

    “total type 1 collagen N-terminal propeptide (TP1NP) is the most critical physiological indicator affecting abnormal bone mineral density”

    Humansperimenopausal women

    Identification and importance analysis of osteoporosis risk factors in perimenopausal women based on the Transformer-LSTM hybrid model and SMOTE

    Climacteric : the journal of the International Menopause Society

Cognitive impairment

upin humans1HR 1.018

1 study
  1. Procollagen type I N-terminal propeptide is associated with cognitive impairment in humans (HR: 1.018, 95%CI: 1.001-1.035).

    “Total type I collagen N-terminal elongation peptide [hazard ratio (HR): 1.018, 95%CI: 1.001-1.035] and prolactin (HR: 1.065, 95%CI: 1.005-1.129) levels were positively and significantly associated with CI”

    Humansfemalesn = 396

    Positive associations between sex hormones, bone metabolism and cognitive impairment in Chinese oldest-old females

    BMC psychiatry

More on Cognitive impairment

Bone mineral density

downin humans1

1 study
  1. Procollagen type I N-terminal propeptide is associated with bone mineral density in humans (very elderly Chinese men).

    “The three turnover markers were moderately correlated to each other (P < 0.001), and all negatively associated with the bone mineral density of three sites (P < 0.05).”

    Humansvery elderly Chinese menmalesn = 1,316

    Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men

    Geriatrics & gerontology international

PTH

upin humans1

1 study
  1. PTH is associated with procollagen type I N-terminal propeptide in humans.

    “The increase in PTH levels with age showed a positive linear correlation with P1NP and β-CTX concentrations and a negative linear correlation with BMD at the lumbar spines and the femoral neck.”

    Humansn = 1,436

    Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

More on PTH

Latest

Dec 2025: 4Jan 2026: 5Feb 2026: 3Mar 2026: 3Apr 2026: 2May 2026: 5Jun 2026: 6Jul 2026: 2Aug 2026: 7Sep 2026: 2Oct 2026: 5Nov 2026: 448 papers in 12 months
Regenerative Therapy

Engineered bone-targeting particles reduced bone loss in mice

Weekly doses of particles carrying instructions for making the bone-building drug teriparatide improved spongy bone structure in a mouse model of osteoporosis.Weekly doses of particles carrying instructions for making the bone-building drug teriparatide improved spongy bone structure in a mouse model of osteoporosis.

Mouse studyBone loss

See all 111 papers on procollagen type I N-terminal propeptide